主动脉瓣狭窄加速时间/射血时间比的预后值

Sergio Gamaza-Chulián , Dolores Ruiz-Fernández , Enrique Díaz-Retamino , Santiago Camacho-Freire , Alberto Giráldez-Valpuesta , Bárbara Serrano-Muñoz , Enrique Otero-Chulián
{"title":"主动脉瓣狭窄加速时间/射血时间比的预后值","authors":"Sergio Gamaza-Chulián ,&nbsp;Dolores Ruiz-Fernández ,&nbsp;Enrique Díaz-Retamino ,&nbsp;Santiago Camacho-Freire ,&nbsp;Alberto Giráldez-Valpuesta ,&nbsp;Bárbara Serrano-Muñoz ,&nbsp;Enrique Otero-Chulián","doi":"10.1016/j.carcor.2017.12.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Guidelines underline the importance of assessment of aortic flow waveform morphology to estimate aortic stenosis (AS) severity. Our aim was to evaluate acceleration time/ejection time ratio (AT/ET) as prognostic value in this disease.</p></div><div><h3>Methods</h3><p>Between January 2013 and July 2016, patients with severe AS (aortic valve area &lt;<!--> <!-->1<!--> <!-->cm<sup>2</sup>) who came to our echocardiography laboratory were included. We analyzed in the aortic flow in continuos Doppler wave the time between the onset and the peak velocity (acceleration time), and total ejection time, and then acceleration time/ejection time ratio was calculated. The primary end-point was a combined one of cardiovascular death or aortic valve replacement.</p></div><div><h3>Results</h3><p>One hundred and ninety-seven patients with severe AS were included (55% women, mean age 76<!--> <!-->±<!--> <!-->8<!--> <!-->years). Complete follow-up was achieved in 190 patients (96%): during a mean follow-up of 223<!--> <!-->±<!--> <!-->156<!--> <!-->days, 110 patients (58%) reached the primary endpoint; 70 patients (37%) were surgically operated, 8 patients (4%) percutaneous replacement, 33 patients (17%) suffered from cardiovascular death. Patients with AT/ET higher than 0.35 had more cardiovascular events (66% vs. 41%, <em>P</em> <!-->=<!--> <!-->.008). There was a non-significant trend to lower free-events survival by Kaplan-Meier method in patients with AT/ET higher than 0.35 (284<!--> <!-->±<!--> <!-->25 vs. 350<!--> <!-->±<!--> <!-->32<!--> <!-->days, <em>P</em> <!-->=<!--> <!-->.07). In multivariate analysis by Cox regression, only aortic valve area (<em>P</em> <!-->=<!--> <!-->.03), atrial fibrillation (<em>P</em> <!-->=<!--> <!-->.02), symptomatic status (<em>P</em> <!-->&lt;<!--> <!-->.001) and AT/ET (<em>P</em> <!-->=<!--> <!-->.04) were independent predictors of combined end-point.</p></div><div><h3>Conclusion</h3><p>AT/ET ratio could help to identify patients with more severe AS. Higher values of AT/ET ratio were associated with higher incidence of aortic valve replacement and/or cardiovascular death.</p></div>","PeriodicalId":100216,"journal":{"name":"Cardiocore","volume":"53 4","pages":"Pages 152-158"},"PeriodicalIF":0.0000,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.carcor.2017.12.002","citationCount":"0","resultStr":"{\"title\":\"Valor pronóstico del ratio tiempo de aceleración/tiempo de eyección en la estenosis valvular aórtica\",\"authors\":\"Sergio Gamaza-Chulián ,&nbsp;Dolores Ruiz-Fernández ,&nbsp;Enrique Díaz-Retamino ,&nbsp;Santiago Camacho-Freire ,&nbsp;Alberto Giráldez-Valpuesta ,&nbsp;Bárbara Serrano-Muñoz ,&nbsp;Enrique Otero-Chulián\",\"doi\":\"10.1016/j.carcor.2017.12.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Guidelines underline the importance of assessment of aortic flow waveform morphology to estimate aortic stenosis (AS) severity. Our aim was to evaluate acceleration time/ejection time ratio (AT/ET) as prognostic value in this disease.</p></div><div><h3>Methods</h3><p>Between January 2013 and July 2016, patients with severe AS (aortic valve area &lt;<!--> <!-->1<!--> <!-->cm<sup>2</sup>) who came to our echocardiography laboratory were included. We analyzed in the aortic flow in continuos Doppler wave the time between the onset and the peak velocity (acceleration time), and total ejection time, and then acceleration time/ejection time ratio was calculated. The primary end-point was a combined one of cardiovascular death or aortic valve replacement.</p></div><div><h3>Results</h3><p>One hundred and ninety-seven patients with severe AS were included (55% women, mean age 76<!--> <!-->±<!--> <!-->8<!--> <!-->years). Complete follow-up was achieved in 190 patients (96%): during a mean follow-up of 223<!--> <!-->±<!--> <!-->156<!--> <!-->days, 110 patients (58%) reached the primary endpoint; 70 patients (37%) were surgically operated, 8 patients (4%) percutaneous replacement, 33 patients (17%) suffered from cardiovascular death. Patients with AT/ET higher than 0.35 had more cardiovascular events (66% vs. 41%, <em>P</em> <!-->=<!--> <!-->.008). There was a non-significant trend to lower free-events survival by Kaplan-Meier method in patients with AT/ET higher than 0.35 (284<!--> <!-->±<!--> <!-->25 vs. 350<!--> <!-->±<!--> <!-->32<!--> <!-->days, <em>P</em> <!-->=<!--> <!-->.07). In multivariate analysis by Cox regression, only aortic valve area (<em>P</em> <!-->=<!--> <!-->.03), atrial fibrillation (<em>P</em> <!-->=<!--> <!-->.02), symptomatic status (<em>P</em> <!-->&lt;<!--> <!-->.001) and AT/ET (<em>P</em> <!-->=<!--> <!-->.04) were independent predictors of combined end-point.</p></div><div><h3>Conclusion</h3><p>AT/ET ratio could help to identify patients with more severe AS. Higher values of AT/ET ratio were associated with higher incidence of aortic valve replacement and/or cardiovascular death.</p></div>\",\"PeriodicalId\":100216,\"journal\":{\"name\":\"Cardiocore\",\"volume\":\"53 4\",\"pages\":\"Pages 152-158\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.carcor.2017.12.002\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiocore\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1889898X17301159\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiocore","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1889898X17301159","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

指南强调了评估主动脉血流波形形态对评估主动脉狭窄(AS)严重程度的重要性。我们的目的是评估加速时间/射血时间比(AT/ET)作为这种疾病的预后价值。方法2013年1月~ 2016年7月,对重度AS患者(主动脉瓣面积<1平方厘米)的患者被纳入我们的超声心动图实验室。分析连续多普勒波主动脉血流的起始至峰值速度之间的时间(加速时间)和总射血时间,计算加速时间/射血时间之比。主要终点是心血管死亡或主动脉瓣置换术的联合终点。结果纳入重度AS患者197例(女性55%,平均年龄76±8岁)。190例患者(96%)实现了完全随访:在223±156天的平均随访期间,110例患者(58%)达到了主要终点;手术70例(37%),经皮置换术8例(4%),心血管死亡33例(17%)。AT/ET高于0.35的患者有更多的心血管事件(66%比41%,P = 0.008)。在AT/ET高于0.35的患者中,Kaplan-Meier法显示自由事件生存率降低的趋势不显著(284±25 vs 350±32,P = 0.07)。多因素Cox回归分析中,只有主动脉瓣面积(P = 0.03)、心房颤动(P = 0.02)、症状状态(P <.001)和AT/ET (P = .04)是联合终点的独立预测因子。结论at /ET比值可以帮助鉴别严重AS患者。较高的AT/ET比值与较高的主动脉瓣置换术和/或心血管死亡发生率相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Valor pronóstico del ratio tiempo de aceleración/tiempo de eyección en la estenosis valvular aórtica

Introduction

Guidelines underline the importance of assessment of aortic flow waveform morphology to estimate aortic stenosis (AS) severity. Our aim was to evaluate acceleration time/ejection time ratio (AT/ET) as prognostic value in this disease.

Methods

Between January 2013 and July 2016, patients with severe AS (aortic valve area < 1 cm2) who came to our echocardiography laboratory were included. We analyzed in the aortic flow in continuos Doppler wave the time between the onset and the peak velocity (acceleration time), and total ejection time, and then acceleration time/ejection time ratio was calculated. The primary end-point was a combined one of cardiovascular death or aortic valve replacement.

Results

One hundred and ninety-seven patients with severe AS were included (55% women, mean age 76 ± 8 years). Complete follow-up was achieved in 190 patients (96%): during a mean follow-up of 223 ± 156 days, 110 patients (58%) reached the primary endpoint; 70 patients (37%) were surgically operated, 8 patients (4%) percutaneous replacement, 33 patients (17%) suffered from cardiovascular death. Patients with AT/ET higher than 0.35 had more cardiovascular events (66% vs. 41%, P = .008). There was a non-significant trend to lower free-events survival by Kaplan-Meier method in patients with AT/ET higher than 0.35 (284 ± 25 vs. 350 ± 32 days, P = .07). In multivariate analysis by Cox regression, only aortic valve area (P = .03), atrial fibrillation (P = .02), symptomatic status (P < .001) and AT/ET (P = .04) were independent predictors of combined end-point.

Conclusion

AT/ET ratio could help to identify patients with more severe AS. Higher values of AT/ET ratio were associated with higher incidence of aortic valve replacement and/or cardiovascular death.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Flecainida y ergometría, ¿aliados o enemigos? ¿Cree que el TAVI va a acabar con la cirugía? Síndrome de marcapasos evaluado mediante ecocardiografía Paraganglioma como causa de taquicardia ventricular maligna en un varón de 69 años Implantación de la prótesis CoreValve® como tratamiento de un homoinjerto valvular aórtico disfuncionante con insuficiencia aórtica predominante
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1